THC
20.3–22.3%
CBD
0.2%
Genetics Split
Seattle Cough, a 70% sativa Haze x Northern Lights #5 hybrid, tests THC between 20.3 percent and 22.3 percent.
No effect, terpene, flavor or medical-use data specific to Seattle Cough has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
22.3% THC
About Seattle Cough
Seattle Cough leans heavily sativa, a 70/30 split built from a cross of Haze and Northern Lights #5, two genetics that couldn't sit much further apart on the classic spectrum, one prized for cerebral, rangy sativa traits and the other for dense, resinous indica structure. That tension shows up in the THC numbers too: testing runs from a strong 20.3% up to 22.3%, firmly in potent territory regardless of which parent's influence shows through more in a given phenotype. No breeder has been confirmed for this cut, and the paperwork doesn't extend to flowering time, yield, terpenes, flavors, effects, or medical applications, so the genetic split and the potency figures are the clearest facts available. Haze and Northern Lights are both storied enough on their own that combining them under a sativa-dominant hybrid label is a notable pairing, even without further detail to round out the picture.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Seattle Cough
Is Seattle Cough an Indica, Sativa, or Hybrid?
Seattle Cough is classified as a hybrid cannabis strain bred from a genetic cross of Haze × Northern Lights #5.
What cannabinoid content is reported for Seattle Cough?
Seattle Cough: 22.3% THC and 0.2% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.